Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin to reduce fungal infections in acute myeloid leukemia
IRCT20210503051166N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atorvastatin in acute myeloid leukemia (AML), sponsored by Mashhad University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
atorvastatin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on IRCT20210503051166N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210503051166N1.